These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25776265)

  • 1. The glycan role in the glycopeptide immunogenicity revealed by atomistic simulations and spectroscopic experiments on the multiple sclerosis biomarker CSF114(Glc).
    Bruno A; Scrima M; Novellino E; D'Errico G; D'Ursi AM; Limongelli V
    Sci Rep; 2015 Mar; 5():9200. PubMed ID: 25776265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
    Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designed glucopeptides mimetics of myelin protein epitopes as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
    Pandey S; Alcaro MC; Scrima M; Peroni E; Paolini I; Di Marino S; Barbetti F; Carotenuto A; Novellino E; Papini AM; D'Ursi AM; Rovero P
    J Med Chem; 2012 Dec; 55(23):10437-47. PubMed ID: 23167575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
    Carotenuto A; D'Ursi AM; Mulinacci B; Paolini I; Lolli F; Papini AM; Novellino E; Rovero P
    J Med Chem; 2006 Aug; 49(17):5072-9. PubMed ID: 16913697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies as biomarkers of multiple sclerosis.
    Carotenuto A; Alcaro MC; Saviello MR; Peroni E; Nuti F; Papini AM; Novellino E; Rovero P
    J Med Chem; 2008 Sep; 51(17):5304-9. PubMed ID: 18712857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferrocenyl glycopeptides as electrochemical probes to detect autoantibodies in multiple sclerosis patients' sera.
    Real-Fernández F; Colson A; Bayardon J; Nuti F; Peroni E; Meunier-Prest R; Lolli F; Chelli M; Darcel C; Jugé S; Papini AM
    Biopolymers; 2008; 90(4):488-95. PubMed ID: 18273890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
    Lolli F; Mazzanti B; Pazzagli M; Peroni E; Alcaro MC; Sabatino G; Lanzillo R; Brescia Morra V; Santoro L; Gasperini C; Galgani S; D'Elios MM; Zipoli V; Sotgiu S; Pugliatti M; Rovero P; Chelli M; Papini AM
    J Neuroimmunol; 2005 Oct; 167(1-2):131-7. PubMed ID: 16051375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains.
    Matsushita T; Sadamoto R; Ohyabu N; Nakata H; Fumoto M; Fujitani N; Takegawa Y; Sakamoto T; Kurogochi M; Hinou H; Shimizu H; Ito T; Naruchi K; Togame H; Takemoto H; Kondo H; Nishimura S
    Biochemistry; 2009 Nov; 48(46):11117-33. PubMed ID: 19852465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
    Niccheri F; Real-Fernàndez F; Ramazzotti M; Lolli F; Rossi G; Rovero P; Degl'Innocenti D
    J Mol Recognit; 2014 Oct; 27(10):618-26. PubMed ID: 25178857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational landscape of N-glycosylated peptides detecting autoantibodies in multiple sclerosis, revealed by Hamiltonian replica exchange.
    Guardiani C; Signorini GF; Livi R; Papini AM; Procacci P
    J Phys Chem B; 2012 May; 116(18):5458-67. PubMed ID: 22519978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
    Real-Fernández F; Passalacqua I; Peroni E; Chelli M; Lolli F; Papini AM; Rovero P
    Sensors (Basel); 2012; 12(5):5596-607. PubMed ID: 22778603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases.
    Nuti F; Peroni E; Real-Fernández F; Bonache MA; Le Chevalier-Isaad A; Chelli M; Lubin-Germain N; Uziel J; Rovero P; Lolli F; Papini AM
    Biopolymers; 2010; 94(6):791-9. PubMed ID: 20564034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody recognition in multiple sclerosis and Rett syndrome using a collection of linear and cyclic N-glucosylated antigenic probes.
    Real Fernández F; Di Pisa M; Rossi G; Auberger N; Lequin O; Larregola M; Benchohra A; Mansuy C; Chassaing G; Lolli F; Hayek J; Lavielle S; Rovero P; Mallet JM; Papini AM
    Biopolymers; 2015 Sep; 104(5):560-76. PubMed ID: 25973844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
    Lolli F; Rovero P; Chelli M; Papini AM
    Neurology; 2005 Sep; 65(5):781-2; author reply 781-2. PubMed ID: 16157927
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
    Pandey S; Dioni I; Lambardi D; Real-Fernandez F; Peroni E; Pacini G; Lolli F; Seraglia R; Papini AM; Rovero P
    Mol Cell Proteomics; 2013 Feb; 12(2):277-82. PubMed ID: 23139387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae.
    Walvoort MT; Testa C; Eilam R; Aharoni R; Nuti F; Rossi G; Real-Fernandez F; Lanzillo R; Brescia Morra V; Lolli F; Rovero P; Imperiali B; Papini AM
    Sci Rep; 2016 Dec; 6():39430. PubMed ID: 28008952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment 101-108 of myelin oligodendrocyte glycoprotein: a possible lead compound for multiple sclerosis.
    Guardiani C; Marsili S; Procacci P; Livi R
    J Am Chem Soc; 2009 Dec; 131(47):17176-84. PubMed ID: 19891505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural elucidation of the polysaccharide moiety of a glycopeptide (GLPCW-II) from Ganoderma lucidum fruiting bodies.
    Ye L; Zhang J; Ye X; Tang Q; Liu Y; Gong C; Du X; Pan Y
    Carbohydr Res; 2008 Mar; 343(4):746-52. PubMed ID: 18179790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.